TransMedics makes the Organ Care System (OCS), a portable device that keeps donor organs alive outside the body using warm, oxygenated perfusion with continuous viability monitoring. The system circulates warmed, nutrient-rich blood through an organ, enabling assessment in near-physiological conditions and supports FDA-approved preservation and assessment for hearts, lungs, and livers. It earns revenue by selling the OCS consoles, selling single-use disposable sets for procedures, and offering the National OCS Program, which provides end-to-end organ retrieval, logistics, and clinical support. Its goal is to increase transplant chances and organ utilization by improving preservation, assessment, and logistics across centers.
Company Size
501-1,000
Company Stage
IPO
Headquarters
Andover, Massachusetts
Founded
1998
See people who can refer or advise you
Help us improve and share your feedback! Did you find this helpful?